Pramipexole 0.75mg ER Tablets

Pramipexole 0.75mg ER Tablets are an extended-release dopamine-agonist treatment for Parkinson's disease. They help manage tremor, stiffness and slowed movement through prolonged dopaminergic activity.
Take the extended-release tablet once daily at a consistent time, with or without food. Swallow it intact without splitting, chewing or crushing. Dose increases, conversion from immediate-release treatment and restarting after an interruption need an individual titration plan.
Pramipexole stimulates dopamine receptors involved in movement control, helping compensate for deficient dopaminergic signalling in Parkinson's disease.
Side effects may include nausea, dizziness, sleepiness, insomnia, constipation, weakness, hallucinations, swelling, low blood pressure, and impulse-control changes.
Avoid driving if sleepy. Report sudden sleep episodes, hallucinations, compulsive behavior, severe dizziness, swelling, or mood changes. Do not stop suddenly.
Can reduce tremor, stiffness and slowed movement in Parkinson's disease, helping with mobility and everyday tasks over the dosing interval.
This extended-release formulation is used for Parkinson's disease. It is not the standard pramipexole formulation for restless legs syndrome.
No. Extended-release treatment is once daily, while immediate-release Parkinson's regimens commonly divide the daily amount. A planned conversion is needed.
No. The tablet must stay intact to preserve its extended-release delivery.
Watch for sleepiness, sudden sleep episodes, dizziness, hallucinations, swelling, nausea, or compulsive behaviors.
No. It should not be stopped suddenly without medical advice.
Tell your doctor if you have kidney disease, psychosis, low blood pressure, or sudden sleep attacks. Also mention if you are pregnant or breastfeeding, or if you take sedating medicines.
Dopamine agonist: stimulates dopamine receptors; Extended release: delivers medicine over a prolonged period; Parkinson's disease: a disorder affecting movement; Impulse-control disorder: difficulty resisting harmful compulsive behaviour; AR: Pramipexole 0.75mg أقراص; FR: Pramipexole 0.75mg comprimé; PT: Pramipexole 0.75mg comprimido; ES: Pramipexole 0.75mg tableta; RU: Pramipexole 0.75mg таблетки; ID: Pramipexole 0.75mg tablet; VI: Pramipexole 0.75mg viên nén; MS: Pramipexole 0.75mg tablet; TL: Pramipexole 0.75mg tableta; ZH-SG: Pramipexole 0.75mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Pramipexole 0.75mg ER Tablets under Neuro Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Pramipexole 0.75mg ER Tablets